Ceradyne Acquires SemEquip, Inc.

Ceradyne, Inc.

Represented Ceradyne, Inc. (Nasdaq: CRDN) in its acquisition of SemEquip, Inc., for up to $125 million. SemEquip develops and markets “cluster molecules” such as B18H22 for use in the ion implantation of boron in the manufacture of semiconductors. Ceradyne develops, manufactures and markets advanced technical ceramic products and components for defense, industrial, energy, automotive/diesel and commercial applications.